TTA-A2
CAS: 953778-63-7
Ref. 3D-DNB77863
Undefined size | Discontinued | ||
5mg | Discontinued | ||
10mg | Discontinued | ||
25mg | Discontinued | ||
50mg | Discontinued | ||
100mg | Discontinued |
Product Information
TTA-A2 is a t-type calcium channel blocker. It has been shown to reduce locomotor activity and activate lymphatic vessels in rats. TTA-A2 is also a potential drug target for metabolic disorders, such as obesity, diabetes, and hypertension. TTA-A2 has been shown to have anti-inflammatory effects on the bowel that may be due to its ability to inhibit intracellular calcium concentration. Other studies have shown that TTA-A2 can be used for the treatment of bowel disease and inflammatory bowel disease. In addition, there are no side effect profiles associated with TTA-A2.